NORTH CHICAGO, Ill., May 25, 2023 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced the New England Journal of Medicine (NEJM) published results from the pivotal Phase 3 clinical trials – U-EXCEL, U-EXCEED and U-ENDURE – evaluating upadacitinib (RINVOQ®) in adult patients with…

Parks Associates’ white paper addresses role of false alarms in undermining consumer trust and examines new standard and solutions designed to resolve these challenges DALLAS, May 25, 2023 /PRNewswire/ — Parks Associates, a leading market research and consulting firm specializing in…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.